Radiation therapy and tamoxifen after breast-conserving surgery: Updated results of a 2×2 randomised clinical trial in patients with low risk of recurrence

Winzer, K.-J.; Sauerbrei, W.; Braun, M.; Liersch, T.; Dunst, J.; Guski, H.; Schumacher, M.; for the German Breast Cancer Study Group (GBSG),

doi:10.1016/j.ejca.2009.10.007

« Previous Next »European Journal of Cancer
Volume 46, Issue 1 , Pages 95-101, January 2010

Radiation therapy and tamoxifen after breast-conserving surgery: Updated results of a 2×2 randomised clinical trial in patients with low risk of recurrence

The paper is dedicated to Prof. Dr. Alfred Schauer (Göttingen) on the occasion of his 80th birthday. He has been one of the driving forces for this and for previous studies of the German Breast Cancer Study Group (GBSG) that have led to the introduction of breast-conserving therapy in Germany. He contributed his internationally recognised expertise in the central histopathological assessment of breast tumours.

K.-J. Winzer
- Interdisciplinary Breast Cancer, Charité Universitätsmedizin, Berlin, Germany
W. Sauerbrei
- Institute of Medical Biometry and Medical Informatics, University Medical Center Freiburg, Germany
M. Braun
- Department of Gynaecology, Zentralkrankenhaus Bremen-Nord, Germany
T. Liersch
- Department of Surgery, Universitätsmedizin Gottingen, Germany
J. Dunst
- Department of Radiotherapy, Universitätsklinikum Halle, Germany
H. Guski
- Institute of Pathology, Universitätsklinikum Charité, Berlin, Germany
M. Schumacher
- Institute of Medical Biometry and Medical Informatics, University Medical Center Freiburg, Germany
- Corresponding author: Address: Universitätsklinikum Freiburg, Med. Biometrie und Informatik, Stefan-Meier-Str. 26, D-79104 Freiburg, Germany. Tel.: +49 (0)761 203 6661; fax: +49 (0)761 203 6680.
for the German Breast Cancer Study Group (GBSG)